在帕金森病中DRD3预测认知障碍和焦虑:易感性和保护作用
Alexandra Gonçalves1,2, Alexandre Mendes3,4,5, Joana Damásio3
1Neuropsychology Service, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
Journal of Parkinson's disease
|February 16, 2024
概括
rs6280 CC 基因型与帕金森病 (PD) 的认知障碍有关,而异质合体基因型可能会防止焦虑. 这种遗传因素不会增加PD的易感性.
科学领域:
- 神经遗传学 神经遗传学
- 认知神经科学 认知神经科学
- 精神病学是一个精神病学.
背景情况:
- 帕金森病 (PD) 认知障碍的遗传基础在很大程度上仍未被探索.
- 多巴胺D3受体 (DRD3) 基因是影响PD认知功能的潜在候选者.
研究的目的:
- 研究DRD3基因中的rs6280 (Ser9Gly) 多态化与PD患者的认知表现之间的关联.
- 在PD的背景下,研究rs6280基因型和精神病理学之间的潜在相互作用.
主要方法:
- 对253名PD患者进行了神经心理评估 (包括DRS-2,HADS) 和神经评估 (UPDRS,H&Y).
- rs6280多态性在PD患者和270名健康对照 (HC) 中被基因型化.
- 统计分析包括非参数组比较和后勤回归,控制共变量.
主要成果:
- 在PD患者和HC患者之间没有观察到rs6280基因型分布的显著差异.
- 与TT基因型相比,患有rs6280 CC基因型的PD患者在与执行功能和视觉构造相关的DRS-2子表现较差.
- rs6280TC基因型与PD患者的焦虑症状减少有关,独立于其他因素.
结论:
- rs6280 CC基因型与PD中的执行功能障碍和视觉结构缺陷有关.
- rs6280异性基因型似乎可以保护PD患者免受焦虑.
- rs6280的多态性似乎不是患PD本身的易感因素.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
14.9K
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.8K
相关概念视频
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Parkinson's Disease: Overview
546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
